Zhejiang Shapuaisi Pharmaceutical Co. Ltd.SSE: 603168

for Diflunisal Tablets

· Issued by Zhejiang Shapuaisi Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Release

Announcement on Obtaining the “Notice of Approval for Drug Supplementary Application” for Diflunisal Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on 6ix

Earlier from Zhejiang Shapuaisi Pharmaceutical

Later from Zhejiang Shapuaisi Pharmaceutical

All Zhejiang Shapuaisi Pharmaceutical news releases